Profile picture

Doctor Isabel Mattig

German Heart Centre Berlin, Berlin (Germany)
Membership: ESC Professional Member EAPCI Member
Follow
Logo ESC

Contributor content

Screening for amyloid cardiomyopathy in patients with aortic stenosis
Presentation
Screening for amyloid cardiomyopathy in patients with aortic stenosis
Trends in tricuspid valve interventions and surgery in Germany from 2018 to 2023
Presentation
Trends in tricuspid valve interventions and surgery in Germany from 2018 to 2023
Refining tricuspid regurgitation grading: do mild-to-moderate and moderate-to-severe categories improve mortality prediction in heart failure patients?
Presentation
Refining tricuspid regurgitation grading: do mild-to-moderate and moderate-to-severe categories improve mortality prediction in heart failure patients?
Meta-analysis of 20 years of research on mortality and sudden cardiac death in Fabry disease: more fear than fatalities?
Presentation
Meta-analysis of 20 years of research on mortality and sudden cardiac death in Fabry disease: more fear than fatalities?
Prognostic significance of tricuspid regurgitation grading using different echocardiographic approaches
Presentation
Prognostic significance of tricuspid regurgitation grading using different echocardiographic approaches
Screening for amyloidosis in patients scheduled for aortic valve replacement
Presentation
Screening for amyloidosis in patients scheduled for aortic valve replacement
Tolerance and clinical response to SGL2 inhibitors in Fabry disease
Presentation
Tolerance and clinical response to SGL2 inhibitors in Fabry disease
Mitral valve thickness: A promising echocardiographic parameter for distinguishing between cardiac amyloidosis and Fabry disease
Presentation
Mitral valve thickness: A promising echocardiographic parameter for distinguishing between cardiac amyloidosis and Fabry disease
New echocardiographic approaches to differentiate cardiac amyloidosis and Fabry disease: the right heart and mitral valve thickness
Presentation
New echocardiographic approaches to differentiate cardiac amyloidosis and Fabry disease: the right heart and mitral valve thickness
Case report on a transthyretin-related amyloidosis caused by Leu32Val mutation and its interdisciplinary challenge.
Presentation
Case report on a transthyretin-related amyloidosis caused by Leu32Val mutation and its interdisciplinary challenge.

ESC 365 is supported by